| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |